TYDICLEAR

This brand name is authorized in Nigeria.

Active ingredients

The drug TYDICLEAR contains one active pharmaceutical ingredient (API):

1	Clobetasol propionate UNII 779619577M - CLOBETASOL PROPIONATE
	Clobetasol propionate, like other topical corticosteroids, has anti-inflammatory, antipruritic, and vasoconstrictive properties. Corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid.
	Read more about Clobetasol propionate

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3821	Cream	Tydiclear Cream CREAM 0.05%	791 Clobetasol Propionate 0.05% B4-3821 Tydiclear Cream Clobetasol Propionate, Microcrystalline Wax, Hard Paraffin, Propylene Glycol, Light Liquid Paraffin, White Soft Paraffin Dermatological Agents Cutaneous/Topical Route Cream Prescription Only Medicine (Pom) Osworth Nigeria Limited Innova Cap Tab India 2021-08-26 2026-08-25	26/08/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AD01	Clobetasol	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AD Corticosteroids, very potent (group IV)
Discover more medicines within D07AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3821